Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.03−0.38 (-4.52%)
Close on Nov 18, 2026Market cap $466.86MP/E –Yield –
Capricor Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Capricor Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$114.90M. For fiscal 2025 it was -$72.72M. The highest annual figure on record is $2.92M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$72.72M | – |
| FY2024 | Dec 31, 2024 | -$41.16M | – |
| FY2023 | Dec 31, 2023 | -$26.91M | -1022.7% |
| FY2022 | Dec 31, 2022 | $2.92M | – |
| FY2021 | Dec 31, 2021 | -$18.01M | – |
| FY2020 | Dec 31, 2020 | -$10.60M | – |
| FY2019 | Dec 31, 2019 | -$6.82M | – |
| FY2018 | Dec 31, 2018 | -$14.18M | – |
| FY2017 | Dec 31, 2017 | -$14.26M | – |
| FY2016 | Dec 31, 2016 | -$14.65M | – |
| FY2015 | Dec 31, 2015 | -$10.95M | -1475.5% |
| FY2014 | Dec 31, 2014 | $795.88K | – |
| FY2013 | Dec 31, 2013 | -$6.20M | – |
| FY2012 | Dec 31, 2012 | -$2.08M | – |
| FY2011 | Dec 31, 2011 | -$4.65M | – |
| FY2010 | Dec 31, 2010 | -$4.32M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$35.55M | – |
| Q1 FY2026 | Mar 31, 2026 | -$34.38M | – |
| Q4 FY2025 | Dec 31, 2025 | -$25.23M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.74M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.41M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.33M | – |
| Q4 FY2024 | Dec 31, 2024 | -$15.29M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.65M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.35M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.88M | -148.6% |
| Q4 FY2023 | Dec 31, 2023 | -$12.15M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.06M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.55M | – |
| Q1 FY2023 | Mar 31, 2023 | $3.86M | -83.5% |
| Q4 FY2022 | Dec 31, 2022 | -$7.60M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.24M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.72M | – |
| Q1 FY2022 | Mar 31, 2022 | $23.48M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.00M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.81M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.84M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.37M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.13M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.13M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.12M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.22M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.79M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.65M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.78M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.61M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.76M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.13M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.69M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.60M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.67M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.21M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.71M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.68M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.58M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.92M | – |
See a number that looks wrong?